港股创新药概念股今日持续走弱，其中荣昌生物（09995）表现尤为疲软，盘中大跌10.88%，引发市场关注。
消息面上，多只创新药概念股今日出现明显跌幅。除荣昌生物外，昭衍新药、石药集团均跌超4%，康龙化成、诺诚健华等亦呈现下挫态势。这表明整个创新药板块可能面临系统性压力，投资者对该行业的短期前景持谨慎态度。
具体到荣昌生物，公司前一交易日的资金流向数据显示，主力资金净流出1021.4万元，占当日总成交额的1.29%。此外，融资融券数据也呈现负面趋势，融资净偿还3079.51万元。这些数据暗示机构投资者可能正在减持该股，进一步加剧了股价下跌的压力。尽管公司2025年中报显示主营收入同比上升48.02%，但净利润仍为亏损状态，这可能引发了市场对公司盈利能力的担忧。在当前市场环境下，投资者似乎更倾向于规避风险，导致资金从亏损企业撤出。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.